In patients with type 2 diabetes, inhaled insulin before each meal, plus insulin glargine before bedtime, is just as effective at controlling blood sugar as conventional twice-daily premixed biaspart insulin therapy, according to new research presented here at the American Diabetes Association (ADA) 70th Scientific Sessions and published in the June 26 issue of the Lancet.
The similarity in benefit comes with 2 important advantages ??t going to need a lot of long-term scrutiny, like any other new drug.”
This study was funded by MannKind. Dr. Lorber has reported financial relationships with Merck & Co, Inc., Novo Nordisk Inc, Biodel Inc., GlaxoSmithKline, Johnson & Johnson, and Roche Pharmaceuticals. Dr. Kirkman has disclosed no relevant financial relationships.
American Diabetes Association (ADA) 70th Scientific Sessions: Presented June 26, 2010.